How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Overview:  Covers the most frequently asked dynamic programming questions in coding interviews.Explains the core DP patterns used by Google, Amazon, Meta, ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

GigaWiper is a destructive backdoor that combines multiple wiping and ransomware-like capabilities into a single operational ...

Rust enters the top 10 for the first time, Python keeps the lead, C moves back above C++, and SQL edges out R in July’s ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' ...

Most security teams think of NTFS junctions and symbolic links as niche file system features. They let one directory point to another, like a shortcut that the OS treats as real. They exist for ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...